C. Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastases Program (PROP) at Princess Margaret Cancer Centre, posted on X:
“Insightful talk on DBCG Skagen Trial and detailed analysis of the relevant data by Birgitte Offersen at GBCC 2026 (Global Breast Cancer Conference). Congrats to the authors for carrying out this important trial.”
Other articles featuring C. Jillian Tsai on OncoDaily.